Αρχική World News Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with... World News Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity Από Ogkologos - 2 Δεκεμβρίου, 2024 1086 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Women Under 35 More Likely to Have Their Breast Cancer Spread 4 Νοεμβρίου, 2021 Enzalutamide Gets Added Approval for Prostate Cancer That Hasn’t Spread 5 Ιανουαρίου, 2024 NHS lung cancer patients in England to get early access to... 9 Σεπτεμβρίου, 2021 Life-saving scheme to improve cancer screening among Muslim women 20 Ιουλίου, 2023 Φόρτωση περισσοτέρων HOT NEWS FDA Approves Neoadjuvant and Adjuvant Pembrolizumab for Resectable Locally Advanced Head... FDA Grants Accelerated Approval to Dabrafenib in Combination with Trametinib for... Test Detects Early Signs of Remaining Cancer in Kids Treated for... Time to get stratified